Catalog |
name |
Description |
price |
R-R-0127 |
p-NCS-Bz-DFO |
p-SCN-Bn-Deferoxamine/p-NCS-Bz-DFO is a specific compound used in molecular imaging and targeted therapy applications.By conjugating p-SCN-Bn-DFO to a targeting molecule, researchers can selectively deliver the radiolabeled compound to a specific target or biomarker in the body. This facilitates the imaging and characterization of disease-specific molecular targets, such as tumors or inflammation sites, using imaging techniques like positron emission tomography (PET). |
price> |
R-R-0349 |
Propargyl-NOTA(tBu)2 |
Propargyl-NOTA(tBu)2 is a chemical compound used in the field of bioconjugation and radiopharmaceutical development for applications in molecular imaging, particularly in nuclear medicine.This compound represents a potential tool for the development of targeted radiopharmaceuticals and molecular imaging probes, contributing to advancements in nuclear medicine for diagnostic, research, and potentially therapeutic applications. |
price> |
R-R-0352 |
1,4,7,10-tetraazacyclodecan-1,4,7,10-tetraacetic acid)-4-nitrophenylester |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid/CAS .474424-15-2, Mono(4-nitrophenyl) ester is a DOTA derivative with one of its acetic acid arms modified with a 4-nitrophenyl ester, potentially for the purposes of further chemical modification, detection, or to alter its metal chelating properties. |
price> |
R-R-0354 |
Azido-mono-amide-DOTA-tris(t-Bu ester) |
Azido-mono-amide-DOTA-tris(t-Bu ester)/CAS:1402795-92-9 is a chemical compound that is used in the field of medicine and biochemistry. It is a derivative of DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid), which is a chelating agent that can form stable complexes with metal ions. The tris(t-Bu ester) modification refers to the presence of three t-butyl ester groups, which can protect the DOTA core and enhance its stability. |
price> |
R-R-0358 |
4-Formyl-N,N,N-trimethylanilinium triflate |
4-Formyl-N,N,N-trimethylanilinium/CAS 124915-02-2 is a bifunctional chelating agent, also known as complexing agent. This organic molecule has a unique structure and can chelate with heavy metal ions to form a stable complex. 4-Formyl-N,N,N-trimethylanilinium is an organic molecule with extremely strong chelating ability that can react with a variety of heavy metal ions to form stable complexes. Compared with traditional complexing agents, 4-Formyl-N,N,N-trimethylanilinium has good selectivity and can react with specific heavy metal ions more effectively. In addition, its chemical properties are stable, not easy to decompose, and can maintain chelating ability for a long time. |
price> |
R-PL-0188 |
Cholesterol-PEG-NOTA |
Cholesterol-polyethylene glycol-NOTA, Cholesterol-PEG-NOTA from ruixi Block copolymers Cholesterol-PEG-NOTA.The nanoscale structures created from block copolymers could potentially be used for creating devices for use in computer memory, nanoscale-templating and nanoscale separations.Polyglutamic acid is a polymer of the amino acid glutamic acid. |
price> |
R-PL-0189 |
Cholesterol-PEG-DTPA |
Cholesterol-polyethylene glycol-Diethyltriamine pentaacetic acid,Cholesterol-PEG-DTPA from ruixi DTPA PEG biotin conjugates were made to chelate metal ions to DTPA. Pegylated DTPA PEG chelators have strong afinity with many metal ions and they are water soluble. Biotin in this PEG conjugate can be bind to avidin or streptavidin. |
price> |
R-M-304 |
NOTA-NHS ester |
NOTA-NHS ester 2 2-(7-(2-((2,5-dioxopyrrolidin-1-yl)oxy)-2-oxoethyl)-1 4 7-triazonane-1 4-diyl)diacetic acid from ruixi.Applications:Peptides and antibodies labeling.Specific reactivity toward primary amines such as lysine group. |
price> |
R-M-305 |
p-SCN-Bn-NOTA,CAS:147597-66-8 |
p-SCN-Bn-NOTA,2-S-(4-Isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid from ruixi. |
price> |
R-M-311 |
Deferoxamine-maleimide |
Deferoxamine is an iron-chelating agent that binds free iron in a stable complex, preventing it from engaging in chemical reactions. Deferoxamine chelates iron from intra-lysosomal ferritin and siderin forming ferrioxamine, a water-soluble chelate excreted by the kidneys and in the feces via the bile. This agent does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. |
price> |